How One Investor Replaced a Salary With Three HMOs

The Income Gap Nobody Talks About

Take a standard three-bedroom house in the Midlands. Rented as a single let, you're looking at somewhere between £850 and £1,100 per month — call it £12,000 a year gross before voids, maintenance, and agent fees eat into it. Now take that same house, convert it into a licensed HMO, and let each room individually. Suddenly you're collecting £400–£550 per room. Five rooms. That's £2,000–£2,750 per month. Same bricks. Same roof. Roughly double the income.

This isn't speculative. HMO Checker's own analysis puts HMO income at 1.5 to 3 times that of a comparable single-let. And at the higher end of the market, the numbers get genuinely striking. Listings on HMOX in June 2026 include a 6-bed Bristol HMO producing £54,900 annual income at a 10.46% gross yield, and a 9-bed West Midlands property generating £63,060 at 11.83%. Compare that to the 5–6% gross yield typical of a standard buy-to-let, as reported by Quartico, and you start to understand why experienced investors migrate toward HMOs and rarely go back.

A Composite Story — But the Numbers Are Real

I want to be clear: what follows is a composite portrait. It's built from patterns I see repeatedly — from investor forums, from deals that pass my desk, from the kind of story that Mark Golder told publicly in March 2026 after leaving a £140,000–£150,000 Managing Director role to build an HMO portfolio using commercial valuations and the Buy-Refurbish-Refinance strategy. The details below are illustrative. The yield figures are real. The income potential is real. The hard parts are very real.

Call her Sarah. Mid-30s. Decent salary — around £38,000 take-home after tax. She'd been a single-let landlord for four years with one property, netting maybe £500 a month after costs. Fine. Not life-changing.

She stumbled across the HMO model almost by accident — a conversation with another landlord at a local property network event. The maths hit her immediately. Her existing BTL was sitting on roughly £90,000 of equity. She hadn't touched it. She didn't know she could.

The Equity Problem — and Why It Stops More Investors Than Anything Else

This is the part that doesn't get enough airtime. The income gap between single-let and HMO is relatively well understood now. What's less discussed is the financing barrier that keeps landlords stuck.

Freeing equity from an existing BTL portfolio to fund an HMO purchase is genuinely difficult. High-street lenders are conservative. Many won't touch HMO remortgages at all, and those that do apply stress tests that can make the numbers look unworkable on paper even when the deal is strong. First-time HMO buyers face an even steeper wall — specialist HMO mortgage products exist, but finding the right one at the right rate without a broker who actually knows this niche is a time-sink that kills deals.

Sarah spent three months trying to remortgage her existing BTL through her current lender. They declined. She went to a comparison site. The products listed didn't fit her situation. She nearly gave up.

What changed it was finding a specialist broker — someone who works with HMO investors specifically, understands commercial valuations, and knows which lenders are actively writing HMO business in the current rate environment. That's not a generic service. That's a niche that takes years to build.

If you're at this stage — sitting on equity you can't seem to access, or trying to finance your first HMO and hitting walls — this is exactly where ZARSK's regulated finance partners come in. They've spent over a decade doing this. The team works specifically with property investors, including those trying to free up equity from existing portfolios and those buying their first HMO. You can explore that route at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property).

Three HMOs. One Salary Replaced.

Back to Sarah. Once the finance was in place, she moved quickly. First HMO: a 5-bed in the East Midlands, fully tenanted, generating £2,400 per month gross. Second: a 6-bed in the same city, slightly higher spec, pulling £2,900 per month. Third — and this is where the model compounds — a 6-bed she sourced already licensed and tenanted, producing £3,100 per month from day one.

Combined gross income: roughly £8,400 per month. Around £100,000 a year before costs. After mortgage payments, management, maintenance, and a sensible void buffer, she's netting somewhere in the region of £55,000–£65,000. That's more than her salary. And it doesn't require her to be at a desk from nine to five.

Is this guaranteed? Absolutely not — and I'd be doing you a disservice to suggest otherwise. HMOs carry higher management complexity than single-lets. Article 4 directions in many UK cities mean you can't just convert any house. Licensing requirements vary by council. Tenant turnover in shared houses can be higher. These are real costs and real risks, and you should factor them in with a qualified financial adviser before making any investment decision.

But the income potential is real. And the investors who are capturing it consistently are the ones who sourced the right properties to begin with.

Sourcing Is Where Most HMO Strategies Die

Here's my honest view: the yield maths on HMOs is not the hard part. Anyone can run a spreadsheet. The hard part is finding the right property — one that's already licensed, or licensable, in an area with genuine tenant demand, at a price that makes the numbers work.

Most investors spend months on Rightmove and Zoopla finding nothing useful. These platforms weren't built for HMO sourcing. They don't filter by room count, licensing status, or HMO-specific yield metrics. You end up scrolling through hundreds of listings that don't fit, or relying on sourcing agents who charge a fee for a property you could have found yourself if you had the right data.

This is the problem ZARSK was built to solve. The database — which I believe is the largest dedicated HMO database in the UK — is constantly updated and built specifically for investors looking for HMO opportunities. You're not adapting a general property portal. You're searching a tool designed for this exact use case. That's a meaningful difference when you're trying to move quickly on a deal.

Start your search at [zarsk.co.uk](https://zarsk.co.uk). If the finance side is the blocker, the regulated partner team is at [zarsk.co.uk/finance-property](https://www.zarsk.co.uk/finance-property). Both matter. The investors who move fastest are the ones who have both pieces in place before they start looking.

The salary-replacement story isn't rare. It's repeatable. But it depends entirely on two things most aspiring HMO investors get wrong: sourcing deals from data built for HMOs rather than adapted from general portals, and solving the finance before the deal appears rather than scrambling after. The investors I see stall are almost always stuck on one of those two points. The ones who move — and keep moving — have both sorted. That's the actual edge. Not a secret strategy. Not a magic yield formula. Just better data and better finance, earlier in the process.